A Phase III Group-Wide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Filgrastim; Prednisone; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 12 Apr 2017 Biomarkers information updated
- 05 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2009 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.